F2 and liver disorder: Patients with clinically significant portal hypertension had higher spleen cT1 (1414 vs 1212 ms; p = 0.001), liver cT1 (1104 vs 874 ms; p = 0.027), Ishak stage (6 vs 1; p = 0.028), prothrombin time (14.9 vs 13.5 s, p = 0.035) and AST/ALT ratio (1.39 vs 0.88; p = 0.021) than those without clinically significant portal hypertension (Table 1).